{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04470544",
            "orgStudyIdInfo": {
                "id": "CAM20CV"
            },
            "organization": {
                "fullName": "Academic and Community Cancer Research United",
                "class": "OTHER"
            },
            "briefTitle": "Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19",
            "officialTitle": "RECOVER: Phase 2 Randomized, Double-Blind Trial TREating Hospitalized Patients With COVID-19 With Camostat MesilatE, a TMPRSS2 Inhibitor",
            "acronym": "RECOVER",
            "therapeuticArea": [
                "Respiratory"
            ],
            "study": "camostat-mesilate-treating-patients-with-hospitalized-patients-with-covid"
        },
        "statusModule": {
            "statusVerifiedDate": "2021-01",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2020-07-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2022-09-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2022-09-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-07-09",
            "studyFirstSubmitQcDate": "2020-07-13",
            "studyFirstPostDateStruct": {
                "date": "2020-07-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2021-01-07",
            "lastUpdatePostDateStruct": {
                "date": "2021-01-11",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Alan Bryce",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Academic and Community Cancer Research United"
            },
            "leadSponsor": {
                "name": "Alan Bryce",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To determine if the reduction in TMPRSS2 activity via direct inhibition with Camostat mesilate combined with standard of care (SOC) treatment will increase the proportion of patients alive and free from respiratory failure at Day 28 in SARS-CoV-2 as compared to SOC treatment with placebo."
        },
        "conditionsModule": {
            "conditions": [
                "Severe Acute Respiratory Syndrome"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 264,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo + Standard of Care",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Standard of Care will be defined by the investigators in collaboration with the sponsor on the basis of the best available evidence at the time of study initiation with placebo.",
                    "interventionNames": [
                        "Other: Standard of Care"
                    ]
                },
                {
                    "label": "Camostat + Standard of Care",
                    "type": "EXPERIMENTAL",
                    "description": "Patient will receive SOC tablets and Camostat mesilate 200 mg four times a day after each meal with Standard of Care treatment.",
                    "interventionNames": [
                        "Drug: Camostat Mesilate"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Camostat Mesilate",
                    "description": "Given PO",
                    "armGroupLabels": [
                        "Camostat + Standard of Care"
                    ],
                    "otherNames": [
                        "Foipan"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Standard of Care",
                    "description": "At Investigator discretion",
                    "armGroupLabels": [
                        "Placebo + Standard of Care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in the proportion of patients alive and free from respiratory failure",
                    "description": "To determine if the reduction in TMPRSS2 activity via direct inhibition with Camostat mesilate combined with standard of care (SOC) treatment will change the proportion of patients alive and free from respiratory failure at Day 28 in SARS-CoV-2 as compared to SOC treatment with placebo.",
                    "timeFrame": "28 Days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in the proportion of patients alive and free of ventilator use or ECMO",
                    "description": "To determine if reduction in TMPRSS2 activity via direct inhibition with Camostat mesilate combined with SOC treatment will change the proportion of patients alive and free of ventilator use or ECMO at Day 28 as compared to SOC treatment combined with placebo.",
                    "timeFrame": "28 Days"
                },
                {
                    "measure": "Mortality Rate",
                    "description": "To determine if the combination of Camostat mesilate combined with SOC treatment will result in a changed mortality rate at 28 and 56 days as compared to SOC treatment combined with placebo.",
                    "timeFrame": "28 and 56 Days"
                },
                {
                    "measure": "Clinical Change",
                    "description": "Clinical change will be defined as a 2 or more point decease on the WHO ordinal scale. Time to clinical improvement will be calculated as the number of days from study entry until the earliest date of clinical change.",
                    "timeFrame": "14 and 28 Days"
                },
                {
                    "measure": "Adverse Events",
                    "description": "Analyses for safety will include all participants who are randomized and received at least 1 dose of study treatment. Participants will be grouped according to the treatment to which they were randomized.",
                    "timeFrame": "up to 56 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Laboratory confirmed SARS-CoV-2 infection\n* Admitted to hospital for management of SARS-CoV-2\n* Age \u226518\n* Subject or legal representative able to give informed consent\n* Ability to take all study drugs\n* Respiratory status of 3 or greater on the WHO ordinal scale\n* ALT or AST \u22645 x ULN\n* Creatinine clearance \u226550 mL/min using the Cockroft-Gault formula\n* Willingness to provide mandatory specimens for correlative research and banking\n\nExclusion Criteria:\n\n* Women who are pregnant or breastfeeding\n* Known hypersensitivity to the study drug, the metabolites or formulation excipient",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "overallOfficials": [
                {
                    "name": "Alan H Bryce, M.D.",
                    "affiliation": "Academic and Community Cancer Research United",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic in Arizona",
                    "status": "RECRUITING",
                    "city": "Scottsdale",
                    "state": "Arizona",
                    "zip": "85259",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Vy Nguyen",
                            "role": "CONTACT",
                            "phone": "480-342-1328",
                            "email": "Nguyen.Vy@mayo.edu"
                        },
                        {
                            "name": "Alan H Bryce, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.50921,
                        "lon": -111.89903
                    }
                },
                {
                    "facility": "Tucson Medical Center",
                    "status": "RECRUITING",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85712",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Natalia Elias Calles",
                            "role": "CONTACT",
                            "phone": "520-324-5512",
                            "email": "ClinicalResearch@tmcaz.com"
                        },
                        {
                            "name": "Robert Aaronson",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "Mayo Clinic in Florida",
                    "status": "RECRUITING",
                    "city": "Jacksonville",
                    "state": "Florida",
                    "zip": "32224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Torsak Vimoktayon",
                            "role": "CONTACT",
                            "phone": "904-953-3238",
                            "email": "Vimoktayon.Torsak@mayo.edu"
                        },
                        {
                            "name": "Stacey Pecenka",
                            "role": "CONTACT",
                            "phone": "904-953-4261",
                            "email": "Pecenka.Stacey@mayo.edu"
                        },
                        {
                            "name": "Sadia Shah, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.33218,
                        "lon": -81.65565
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "submissionTracking": {
                "estimatedResultsFirstSubmitDate": "2024-02-29",
                "submissionInfos": [
                    {
                        "releaseDate": "2024-02-29",
                        "resetDate": "2024-03-27",
                        "mcpReleaseN": 4
                    }
                ]
            }
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000045169",
                    "term": "Severe Acute Respiratory Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012141",
                    "term": "Respiratory Tract Infections"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000018352",
                    "term": "Coronavirus Infections"
                },
                {
                    "id": "D000003333",
                    "term": "Coronaviridae Infections"
                },
                {
                    "id": "D000030341",
                    "term": "Nidovirales Infections"
                },
                {
                    "id": "D000012327",
                    "term": "RNA Virus Infections"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M2561",
                    "name": "COVID-19",
                    "relevance": "LOW"
                },
                {
                    "id": "M25445",
                    "name": "Severe Acute Respiratory Syndrome",
                    "asFound": "Severe Acute Respiratory Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14978",
                    "name": "Respiratory Tract Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M20490",
                    "name": "Coronavirus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6555",
                    "name": "Coronaviridae Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M23685",
                    "name": "Nidovirales Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15149",
                    "name": "RNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T5186",
                    "name": "Severe Acute Respiratory Syndrome",
                    "asFound": "Severe Acute Respiratory Syndrome",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000034532",
                    "term": "Camostat"
                }
            ],
            "ancestors": [
                {
                    "id": "D000011480",
                    "term": "Protease Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000014361",
                    "term": "Trypsin Inhibitors"
                },
                {
                    "id": "D000015842",
                    "term": "Serine Proteinase Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M207114",
                    "name": "Camostat",
                    "asFound": "Health Survey",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19609",
                    "name": "HIV Protease Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M14343",
                    "name": "Protease Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M17112",
                    "name": "Trypsin Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M18391",
                    "name": "Serine Proteinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "T18",
                    "name": "Serine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}